Items where authors include "Morgan, C"

Article

McNamara, MG, Swain, J, Craig, Z et al. (21 more authors) (2023) NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma. eClinicalMedicine, 60. 102015. ISSN 2589-5370

Ferraro, L, Quattrone, D, La Barbera, D et al. (33 more authors) (2022) First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data. Schizophrenia Bulletin. sbac100. ISSN 0586-7614

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Ahmed, WUR, Bhatia, S, McLean, KA et al. (4545 more authors) (2022) Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery. BJS Open, 6 (1). zrab150. ISSN 2474-9842

Wakeham, K, Murray, L orcid.org/0000-0003-0658-6455, Muirhead, R et al. (10 more authors) (2021) Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy. Clinical Oncology, 33 (10). pp. 638-649. ISSN 0936-6555

Ferraro, L, La Cascia, C, La Barbera, D et al. (39 more authors) (2021) The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study. Schizophrenia research, 236. pp. 69-79. ISSN 0920-9964

Quattrone, D, Reininghaus, U, Richards, AL et al. (42 more authors) (2021) The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Translational Psychiatry, 11. 423. ISSN 2158-3188

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Quattrone, D, Ferraro, L, Tripoli, G et al. (39 more authors) (2020) Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study. Psychological Medicine. ISSN 0033-2917

Bluett, J, Morgan, C, Thurston, L et al. (7 more authors) (2015) Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Rheumatology, 54 (3). pp. 494-499. ISSN 1462-0324

Ashley, R, Lundy, L, Ward, S et al. (6 more authors) (2013) Water-sensitive urban design: opportunities for the UK. Proceedings of the Institution of Civil Engineers: Municipal Engineer, 166 (ME2). 65 - 76. ISSN 0965-0903